Cargando…

1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV

BACKGROUND: Persons living with HIV (PLWH) are frequently hospitalized for reasons often unrelated to HIV. Transitioning of antiretroviral therapy (ART) while inpatient may not always be an immediate priority due to lack of knowledge, formulary restrictions, and patient status. This could lead to me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladak, Amber, Young, Henry N, Tang, Emily, Curtis, Jessica, Chastain, Daniel B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776397/
http://dx.doi.org/10.1093/ofid/ofaa439.1208
_version_ 1783630673443028992
author Ladak, Amber
Young, Henry N
Tang, Emily
Curtis, Jessica
Chastain, Daniel B
author_facet Ladak, Amber
Young, Henry N
Tang, Emily
Curtis, Jessica
Chastain, Daniel B
author_sort Ladak, Amber
collection PubMed
description BACKGROUND: Persons living with HIV (PLWH) are frequently hospitalized for reasons often unrelated to HIV. Transitioning of antiretroviral therapy (ART) while inpatient may not always be an immediate priority due to lack of knowledge, formulary restrictions, and patient status. This could lead to medication errors and gaps in therapy, which can persist at discharge, and could lead to viral rebound and disease progression. The purpose of this study was to identify effects of hospitalization on ART for PLWH. METHODS: This was an IRB approved, multi-center, retrospective cohort study of patients with HIV and/or AIDS based on ICD codes. Patients were included if they were at least 18 years old, receiving outpatient ART prior to admission, and hospitalized between March 2016 and March 2018. Patients were excluded if they were pregnant and only received intravenous zidovudine during their hospitalization. The primary objective was to determine the rate of ART restarted during hospitalization. Secondary objectives included rate at which inpatient ART was modified compared to outpatient regimen, and risk factors associated with regimen modification. RESULTS: Of 400 patients screened, 295 (74%) patients were on an outpatient ART regimen and were included in the study. Approximately half, 51%, were on a single tablet regimen (STR) outpatient. This population was majority male (59%) and of black race (87%). Median age was 49 years. Median CD4 count was 160 cells/mm3, while median HIV RNA for those with detectable viral load was 57,095 copies/mL. 236 of 295 patients (80%) received ART during their inpatient stay. However, 70 (30%) of these patients received a regimen that differed from their outpatient ART regimen. 69% of regimens were modified for reasons other than to optimize therapy. Patient sex, place of admission, and receipt of a STR or multi-tablet regimen (MTR) as an outpatient did not significantly impact rate of regimen modification. CONCLUSION: Ensuring appropriate transition of ART during hospitalization remains an area in need of improvement. No one specific factor was associated with whether outpatient ART was appropriately and accurately restarted during hospitalization. Thus, there are many opportunities to improve transitions of care and antiretroviral stewardship. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776397
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77763972021-01-07 1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV Ladak, Amber Young, Henry N Tang, Emily Curtis, Jessica Chastain, Daniel B Open Forum Infect Dis Poster Abstracts BACKGROUND: Persons living with HIV (PLWH) are frequently hospitalized for reasons often unrelated to HIV. Transitioning of antiretroviral therapy (ART) while inpatient may not always be an immediate priority due to lack of knowledge, formulary restrictions, and patient status. This could lead to medication errors and gaps in therapy, which can persist at discharge, and could lead to viral rebound and disease progression. The purpose of this study was to identify effects of hospitalization on ART for PLWH. METHODS: This was an IRB approved, multi-center, retrospective cohort study of patients with HIV and/or AIDS based on ICD codes. Patients were included if they were at least 18 years old, receiving outpatient ART prior to admission, and hospitalized between March 2016 and March 2018. Patients were excluded if they were pregnant and only received intravenous zidovudine during their hospitalization. The primary objective was to determine the rate of ART restarted during hospitalization. Secondary objectives included rate at which inpatient ART was modified compared to outpatient regimen, and risk factors associated with regimen modification. RESULTS: Of 400 patients screened, 295 (74%) patients were on an outpatient ART regimen and were included in the study. Approximately half, 51%, were on a single tablet regimen (STR) outpatient. This population was majority male (59%) and of black race (87%). Median age was 49 years. Median CD4 count was 160 cells/mm3, while median HIV RNA for those with detectable viral load was 57,095 copies/mL. 236 of 295 patients (80%) received ART during their inpatient stay. However, 70 (30%) of these patients received a regimen that differed from their outpatient ART regimen. 69% of regimens were modified for reasons other than to optimize therapy. Patient sex, place of admission, and receipt of a STR or multi-tablet regimen (MTR) as an outpatient did not significantly impact rate of regimen modification. CONCLUSION: Ensuring appropriate transition of ART during hospitalization remains an area in need of improvement. No one specific factor was associated with whether outpatient ART was appropriately and accurately restarted during hospitalization. Thus, there are many opportunities to improve transitions of care and antiretroviral stewardship. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776397/ http://dx.doi.org/10.1093/ofid/ofaa439.1208 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Ladak, Amber
Young, Henry N
Tang, Emily
Curtis, Jessica
Chastain, Daniel B
1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
title 1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
title_full 1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
title_fullStr 1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
title_full_unstemmed 1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
title_short 1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
title_sort 1022. impact of hospitalization on antiretroviral therapy for people living with hiv
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776397/
http://dx.doi.org/10.1093/ofid/ofaa439.1208
work_keys_str_mv AT ladakamber 1022impactofhospitalizationonantiretroviraltherapyforpeoplelivingwithhiv
AT younghenryn 1022impactofhospitalizationonantiretroviraltherapyforpeoplelivingwithhiv
AT tangemily 1022impactofhospitalizationonantiretroviraltherapyforpeoplelivingwithhiv
AT curtisjessica 1022impactofhospitalizationonantiretroviraltherapyforpeoplelivingwithhiv
AT chastaindanielb 1022impactofhospitalizationonantiretroviraltherapyforpeoplelivingwithhiv